Kenneth Fine, MD
Sports Medicine · Rockville, MDNPI 1851367973
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (39.7%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Pacira Therapeutics, Inc. at 34.9% of the total. Reporting peaked in 2019 at $7,288 and has fallen 93.5% since, to $475 in 2025.
Across 94 payments — averaging $139.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Therapeutics, Inc.$5K
- Supreme Orthopedic Systems, LLC$4K
- Zimmer Biomet$2K
- Smith+Nephew$1K
- Pacira Pharmaceuticals Incorporated$839
- Miach Orthopaedics, Inc.$214
- plus $744 from 11 others
What the payments were for
- Speaking & faculty fees$4,36033%
- Travel & lodging$1,1679%
- Food & beverage$2,35618%
- Education$5,19040%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Therapeutics, Inc. | 12 | $4,557 |
| Supreme Orthopedic Systems, LLC | 8 | $3,868 |
| Zimmer Biomet | 8 | $1,582 |
| Smith+Nephew | 15 | $1,269 |
| Pacira Pharmaceuticals Incorporated | 16 | $839 |
| Miach Orthopaedics, Inc. | 1 | $214 |
| Johnson & Johnson | 10 | $205 |
| Fidia Pharma USA Inc. | 7 | $132 |
| Ferring Pharmaceuticals Inc. | 6 | $103 |
| Innovation Technologies Inc | 1 | $95 |
| Stryker | 3 | $81 |
| Amgen | 2 | $43 |
| Sanofi-aventis U.S. LLC | 1 | $23 |
| Bioventus LLC | 1 | $18 |
| Normatec Industries, LP | 1 | $15 |
| Siemens Medical Solutions USA, Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Zilretta$4,322
- ROSA-Knee$617
- Iovera$524
- Persona$423
- Comprehensive Anatomic$347
- Journey PFJ$201
- Journey Uni$201
- Regeneten$164
- Comprehensive Reverse$126
- EXPAREL$110
- NOVOSTITCH$106
How this compares
$13,073 in reported general payments places this provider in the 80th percentile of 111 sports medicine providers in Maryland.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 115 | $1,276 |
| Gabapentin | 17 | $142 |
| Cyclobenzaprine Hcl | 11 | $50 |
| Meloxicam | 15 | $49 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Rockville
- Barry BodenRockville$1K
- John FerrellRockville$716
- Garrett LynchAnnapolis$1.4M
- Raymond ThalBethesda$779K
- Jason ScoppSalisbury$637K
- John ChristoforettiBethesda$418K
- Jonas RudzkiChevy Chase$386K
- Matthew LevineFrederick$364K
- Abdulaziz AhmedBaltimore$85K
- Taylor WileySalisbury$53K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.